MRI联合应用DWI和DCE扫描序列在发现肝癌切除术后肝内复发微小癌灶的价值分析

doi:10.3969/j.issn.1672-5069.2017.05.036

Abstract

Yin Tingting Gu Hong，Yang Runiu，et al.. Application of contrast-enhanced MR imaging with DWI and DCE in diagnose of recurrent micro-tumor foci in patients with hepatocellular carcinoma after hepatectomy[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(5): 625-626.

References

[1] 过川根，张景峰，许顺良，等. 磁共振弥散加权成像联合动态增强在肝癌患者TACE术后病灶残留及复发监测中的应用价值.浙江大学学报（医学版），2014，43（1）:77-82，88.
[2] 刘静静，王劲，颜荣华，等. 常规磁共振成像与磁共振弥散加权成像在不同分化小肝癌中的临床应用.中华肝胆外科杂志，2012，18（8）:573-577.
[3] 张学琴，陆健，王霄英，等. DWI 对乙肝肝硬化背景微小肝癌（≤1cm）的检测价值. 实用放射学杂志，2015，23（2）:247-250.
[4] 王阁，李建. 重视影像学检查在肝占位性病变鉴别诊断中的地位. 实用肝脏病杂志，2013，16（5）：385-387.
[5] 贺斌. 磁共振动态增强检查和弥散加权成像在肝结节性病变与小肝癌诊断的对比研究. 肝脏，2015，20（7）:510-512.
[6] 柏根基，张建淮，王书中，等. 微小肝癌的MDCT和MRI诊断比较研究. 实用医学杂志，2012，28（16）:2762-2763.
[7] 项昆，赵鹤亮，张亚杰，等. 多排螺旋 CT 与 MRI 对乙型肝炎肝硬化背景小肝癌检出的比较研究. 医学综述，2015，20（4）:744-745.
[8] 杨景震，王成健，霍英杰，等.3.0T MR 检出和诊断<1.0cm 微小肝癌应用体会.实用放射学杂志，2014，16（8）:1415-1418.
[9] 江凯. 小肝癌治疗新进展. 肝胆胰外科杂志，2013，25（3）:255-257.
[10] Pinteus S，Horta A. High cytotoxicity and anti-proliferative activity of algae extracts on an in vitro model of human hepatocellular carcinoma. Springerplus，20165（1）:1339.
[11] 徐鹏举，严福华，曾蒙苏，等. 局灶性结节增生与肝细胞癌MR扩散加权成像表现特征的比较.中华放射学杂志，2011，45（8）:747-751.
[12] 陈景标，王劲，单鸿，等. 小肝癌的手术与微创治疗的现状及研究进展. 中华肝脏病杂志，2014，22（11）:868-871.
[13] 袁振国，杨金永，赵斌，等. DCE-MRI联合DWI诊断小肝癌的临床价值. 医学影像学杂志，2012，22（10）:1696-1698.
[14] Liu Y，Sun L，Su X，et al. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis，growth and survival of human hepatocellular carcinoma. Biomed Pharmacother，2016，84:237-243.

[1]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[2]	. Consensus on the diagnosis and therapy of hepatic fibrosis [J]. Journal of Practical Hepatology, 2019, 22(6): 793-803.
[3]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[4]	Zeng Yanni, Zhang Can, Bi Junying, et al.. Value of long-time delayed enhancement scan of MRI in the diagnosis of solitary necrotic nodule of liver [J]. Journal of Practical Hepatology, 2019, 22(6): 900-903.
[5]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[6]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[7]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[8]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[9]	Jin Lianghong, Li Xingjie, Guan Hongbo, et al. Clinical value of dual-energy CT iodine quantification combined with dynamic contrast-enhanced MRI in evaluating hepatic hemodynamics and liver functions in patients with hepatitis B liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 712-715.
[10]	Zhu Jun, Ding Ying, Wang Shiqing, et al. Peripheral blood Th22 cells and plasma interleukin-22 level changes in patients with hepatocellular carcinoma after hepatectomy and administration of ulinastatin [J]. Journal of Practical Hepatology, 2019, 22(5): 720-723.
[11]	Wang Gang, Zhao Hongbo, Zhu Yaling, et al. Cancerous XPO5 gene level in patients with hepatocellular carcinoma and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(5): 724-727.
[12]	Hong Jia, Wu Xiaoning, You Hong. Standardized diagnosis of cholestatic liver diseases [J]. Journal of Practical Hepatology, 2019, 22(5): 758-760.
[13]	Cheng Hua, Ju Hui, Song Deshun et al. Value of serum angiopoietin-like protein 2 and Golgi protein 73 levels in the diagnosis of hepatic fibrosis in patient with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 494-497.
[14]	Yu Yingfang, Wen Shengbao. Assessment of liver fibrosis with diffusion-weighted magnetic resonance imaging using single, double and stretch index model in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 502-505.
[15]	Zhang Yafei, Ye Jun, Xie Qinxiu, et al. Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.

Application of contrast-enhanced MR imaging with DWI and DCE in diagnose of recurrent micro-tumor foci in patients with hepatocellular carcinoma after hepatectomy

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments